Kura Oncology to Participate in the JMP Securities Hematology and Oncology Summit

<p>SAN DIEGO, Nov. 28, 2023 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the JMP Securities […]</p>
<p>The post <a href="https://forextv.com/top-news/kura-oncology-to-participate-in-the-jmp-securities-hematology-and-oncology-summit/">Kura Oncology to Participate in the JMP Securities Hematology and Oncology Summit</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>